Impact of Previous Biologic Use on Efficacy and Safety of Brodalumab and Ustekinumab in Patients With Moderate-To-Severe Plaque Psoriasis: Integrated Analysis of AMAGINE-2 and AMAGINE-3
British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.16464
Full Text
Open PDFAbstract
Available in full text
Date
May 23, 2018
Authors
Publisher
Wiley